Blindness clinical trials in California
3 studies for Blindness are looking for participants at sites in California.
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
- Adverum Clinical Site 109, Bakersfield
- Adverum Clinical Site 100, Beverly Hills
- Adverum Clinical Site 201, Campbell
- and 10 more
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Sep 24, 2026 · NCT07482176Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 109, Bakersfield
- Adverum site 169, Fullerton
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Jun 25, 2026 · NCT06891443From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.